Rate this item
(1 Vote)

The 14th International Congress on Autoimmunity (ICA) was held at the Ljubljana Exhibition and Convention Centre, May 17th-20th in Ljubljana, Slovenia.

Rate this item
(1 Vote)

The recent Transplant Sessions brought together Werfen colleagues and partners for two dynamic days of collaboration, innovation, and strategic planning.

Rate this item
(1 Vote)

 

15thAHS

Riyadh, November 6, 2024 – The Werfen EEMEA Event in Riyadh hosted the 15th Advanced Hemostasis Seminar, a full-day event dedicated to exploring the latest advancements and challenges in the field of hemostasis.

Rate this item
(1 Vote)

In November 2024, with our estimated partner AFMS, the EEMEA Marketing and Scientific Team organized in Riyadh (KSA) the 2024 edition of the Scientific Seminars.

18th annual EAHAD Congress

Rate this item
(1 Vote)

February has been a memorable month in terms of Werfen Participation in Scientific Events for Hemostasis.

The 18th Annual EAHAD Congress (European Association for Haemophilia and Allied Disorders) in Milan provided an excellent opportunity to explore the latest advancements in Hemophilia and Allied Disorders.

Rate this item
(1 Vote)

 

ISBT

The 35th Regional ISBT Congress, our largest Transfusion International congress, is taking place in Milan from May 31 - June 4, 2025. Werfen is attending ISBT with a 90 sqm booth.

EFI Conference 2025

Rate this item
(1 Vote)

EFI logo

EFI is here again!

The 38th EFI Conference, our largest annual European Transplant conference, is taking place in Prague, Czech Republic, 14-17 May 2025.

Lab Quality Days

Rate this item
(1 Vote)

The LabQuality Days 2025 congress in Helsinki was a resounding success, bringing together leading professionals in laboratory medicine and healthcare technology.

Rate this item
(2 votes)

GTH has held a conference in Germany, Austria or Switzerland every year and has established itself as the world’s second largest specialist society in the field of thrombosis and haemostasis.

EuroMedLab 2025

Rate this item
(1 Vote)

EuroMedLab 2025 took place in Brussels from 18th to 22nd of May.

EEMEA New Digital Approach

Rate this item
(1 Vote)

The new approach that Werfen is applying to the management of Promotional Marketing Material has been implemented from mid-May 2025.

Rate this item
(1 Vote)

Werfen has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) Reagents.

Page 7 of 34

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top